Torque Teno病毒可预测肾移植后恶性肿瘤
这项前瞻性单中心观察性研究纳入2016至2019年在奥地利维也纳总医院接受肾移植的428例患者,检测血浆TTV载量,主要终点为移植后2至5年首发恶性肿瘤。53例发生恶性肿瘤(53%为皮肤角化细胞癌),移植后4至12个月平均log10 TTV载量与恶性肿瘤风险相关,未调整HR为1.25(95%CI 1.02-1.54),调整后HR为1.20(95%CI 0.97-1.48)。logTTVm4-12>8者HR为2.10(95%CI 1.22-3.60)。
要点
- 移植后4至12个月高TTV载量提示过度免疫抑制,与恶性肿瘤风险升高相关。
- logTTVm4-12>8(既往提出的感染风险cut-off)者恶性肿瘤风险HR为2.10。
- 监测TTV或可作为个体化免疫抑制治疗、降低癌症风险的策略。
核心结论
- 高TTV载量提示强烈免疫抑制状态,可预测肾移植后恶性肿瘤发生。
研究设计与样本
- 前瞻性观察性单中心研究,纳入2016至2019年在奥地利维也纳总医院接受肾移植的428例患者。
- 血浆TTV采用定量聚合酶链反应检测,主要终点为移植后2至5年首发恶性肿瘤发生率。
主要发现
- 共53例发生恶性肿瘤,其中53%为皮肤角化细胞癌。
- 移植后4至12个月平均log10 TTV载量与恶性肿瘤风险升高相关,未调整HR为1.25(95%CI 1.02-1.54)。
- 调整年龄、性别、吸烟和体重指数后HR为1.20(95%CI 0.97-1.48)。
- 亚组中额外调整他克莫司和霉酚酸暴露后结果一致,HR为1.31(95%CI 1.03-1.67)。
- logTTVm4-12>8者HR为2.10(95%CI 1.22-3.60)。
临床怎么用
- 可将TTV载量作为免疫抑制程度的辅助标志物,用于识别恶性肿瘤高风险肾移植受者。
- 对移植后4至12个月TTV载量偏高者,可考虑个体化调整免疫抑制方案以降低癌症风险。
局限性
- 单中心观察性研究,结果需多中心验证。
- 调整年龄、性别、吸烟和体重指数后HR的95%CI包含1。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND HYPOTHESIS: Malignancy, driven by the effects of immunosuppression, is a major complication following kidney transplantation. The widespread and non-pathogenic Torque Teno virus (TTV) has emerged as a surrogate of the immune status of its host, with prior studies linking TTV load to insufficient and excessive immunosuppression and thus indirectly to graft rejection and infection. Its relationship to malignancy in kidney transplant recipients is unknown. METHODS: This prospective observational single center study evaluated 428 patients who underwent kidney transplantation between 2016 and 2019 at the General Hospital of Vienna, Austria. TTV was measured by quantitative polymerase chain reaction in plasma and the primary outcome was the incidence of the first malignancy during years 2-5 post-transplant. RESULTS: In total, 53 patients developed malignancy (53% cutaneous keratinocyte cancer). The mean log10 TTV load during months 4 to 12 post-transplant (logTTVm4-12) was associated with increased malignancy risk with a hazard ratio (HR) of 1.25 [95% confidence interval (CI) 1.02-1.54] in unadjusted analysis and 1.20 (95% CI 0.97-1.48) after adjustment for age, sex, smoking, and body mass index. In a subgroup, the result remained consistent after additional adjustment for tacrolimus and mycophenolate exposure (HR 1.31, 95% CI 1.03-1.67). Patients with logTTVm4-12 >8, a cut-off we previously proposed to indicate infection risk, had an HR of 2.10 (95% CI 1.22-3.60). CONCLUSIONS: These findings suggest that a high TTV load-indicating a state of intense immunosuppression-predicts malignancy after kidney transplantation. Monitoring TTV as a marker of immunosuppression may offer a novel strategy for personalizing immunosuppressive therapy and reducing cancer risk.
引用
- Herz CT, Haupenthal F, Herkner F, et al. Torque Teno virus is predictive for malignancies after kidney transplantation. Nephrol Dial Transplant. 2026. PMID: 41947733. doi:10.1093/ndt/gfag078
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。